Afyx Development A/SAktiv

CVR 35839739Stiftet 2014

Økonomiske nøgletal

-5.044.782 kr.+40,1%
Bruttofortjeneste 2025
-10 mio.-7,5 mio.-5 mio.-2,5 mio.02022202320242025

Nøgletal

2025
Balancens sammensætning
OmsætningsaktiverAnlægsaktiverGæld og hensatte forpligtelserEgenkapital
050 mio.100 mio.150 mio.’17’18’19’20’21’22’23’24’25

Selskabsskat

indkomstår 2023

Virksomheden er sambeskattet. Skatten opgøres samlet hos administrationsselskabet Afyx Capital ApS.

2023Skattepligtig indkomst -6.535.948 kr.0 kr.
2022Skattepligtig indkomst -20.153.758 kr.0 kr.
2021Skattepligtig indkomst -17.015.952 kr.0 kr.
2020Skattepligtig indkomst -30.531.264 kr.0 kr.
2019Skattepligtig indkomst -39.926.771 kr.0 kr.
Selskabsskat →

Kilde: Skattestyrelsens offentlige skattelister for selskaber. Beregnet skat for indkomståret; kan være lavere end 22 % af indkomsten, fx ved skat betalt i udlandet. sktst.dk

Regnskabstal2017–2025
201720182019202020212022202320242025
Balance — aktiver
Likvide beholdninger96.211.65352.027.88142.125.44138.752.42517.435.16711.408.9983.371.794292.83667.189
Omsætningsaktiver i alt103.084.29059.742.90348.397.41344.820.93025.126.25813.062.6554.499.7303.175.1803.710.641
Anlægsaktiver i alt400.5002.418.1273.059.6322.998.0833.331.7113.201.10611.5650—
Aktiver i alt103.484.79062.161.03051.457.04547.819.01328.457.96916.263.7614.511.2953.175.1803.710.641
Balance — passiver
Kortfristede gældsforpligtelser4.197.9577.929.50754.621.640100.802.896116.491.809128.572.5512.108.5406.168.91510.964.628
Langfristede gældsforpligtelser——340.6910——0——
Gældsforpligtelser i alt4.197.9577.929.50754.962.331100.802.896116.491.809128.572.5512.108.5406.168.91510.964.628
Selskabskapital275.315550.630550.630550.630550.630550.630944.9411.000.0001.000.000
Overført resultat99.011.51853.680.893-5.512.838-55.568.742-91.335.914-115.607.115-125.597.858-3.993.735-8.253.987
Årets resultat-25.565.391-45.055.310-57.736.809-49.478.597-35.049.956-24.274.950-9.990.744-6.896.490-4.260.251
Egenkapital i alt99.286.83354.231.523-3.505.286-52.983.883-88.033.840-112.308.7902.402.755-2.993.735-7.253.987
Resultatopgørelse
Bruttofortjeneste—————-8.601.049-4.707.963-8.423.909-5.044.782
Resultat af primær drift-28.494.134-51.082.718-63.306.099-45.827.944-34.418.402-13.533.683-11.008.856-8.726.086-5.044.782
EBITDA-28.494.134-50.688.216-62.806.796-45.328.641-33.919.099-13.034.380-10.904.055-8.726.086—
Resultat før skat-30.833.569-50.637.172-63.236.809-54.978.597-40.330.199-25.424.301-10.939.164-8.841.653-5.461.877
Årets resultat-25.565.391-45.055.310-57.736.809-49.478.597-35.049.956-24.274.950-9.990.744-6.896.490-4.260.251
Personaleomkostninger5.106.38413.062.17210.330.6309.097.5746.476.8554.433.3316.196.092302.1770
Af- og nedskrivninger0394.502499.303499.303499.303499.303104.8010—
Andre nøgletal
Ansatte38101063313

En streg (—) betyder, at der ikke er indsendt årsrapport, eller at posten ikke fremgår af den; 0 er et nul angivet i årsrapporten.

Om virksomheden

Årsrapport 2025

The Company's principal activitiesThe Company’s activities comprise research and development in biotechnology and pharmaceutical medicine. The Company’s proprietary Rivelin® patch is flexible, biodegradable, and adhesive to mucosal surfaces. This innovative patch is designed to deliver medication directly to mucosal surfaces, providing targeted and efficient treatment options for various conditions.Additionally, the Company is developing a nasal spray for the administration of S-ketamine, aimed at providing rapid relief for cluster headaches.

Development in the activities and the financial situation of the CompanyThe Company's Income Statement of the financial year 1 January 2025 - 31 December 2025 shows a result of DKK -4.260.251 and the Balance Sheet at 31 December 2025 a balance sheet total of DKK 3.710.641 and an equity of DKK -7.253.987.

Uddrag af ledelsesberetningen i den seneste årsrapport.

Afyx Development A/S — cvrprofil.dk